EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review

Martina Musarra, Mariafernanda Danzè, Mariapia Marafioti, Giordana Di Mauro, Dalila Incognito, Jessica Alejandra Portillo Funes, Tindara Franchina, Mariacarmela Santarpia, Marco Donato, Giuliana Ciappina, Maria Concetta Ingemi

Case Reports in Oncology · 29.04.2026 · 19 (1) · 767-776

DOI: 10.1159/000552141 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 29.04.2026. Verfasst von Martina Musarra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Pathology "G. Barresi", School of Specialization in Medical Oncology, University of Messina, Messina, Italy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

HER2-positive (HER2+) breast cancer (BC) is associated with a high incidence of brain metastases (BMs), which negatively affect prognosis and quality of life. Local therapies, such as whole-brain radiotherapy (WBRT), stereotactic radiotherapy, stereotactic radiosurgery, and neurosurgery, allow temporary control of metastatic spread. Systemic treatments are limited by the blood-brain barrier (BBB), which restricts the passage of many therapeutic molecules. Research initially focused on small molecule tyrosine kinase inhibitors due to their low molecular weight. Recent evidence suggests that tumor-induced disruption of the BBB may increase its permeability, potentially allowing larger molecules, including antibody-drug conjugates, to cross. Although trastuzumab deruxtecan (T-DXd) has demonstrated intracranial activity, evidence of durable complete responses in heavily pretreated patients with active BMs remains limited. Case Presentation: We report a case of a HER2+ BC patient with multiple (>20) active BMs, previously treated with WBRT and trastuzumab emtansine (T-DM1), who developed intracranial progression. Third-line treatment with T-DXd resulted in a complete radiological intracranial response, which has been maintained for more than 20 months under ongoing therapy, with associated improvement in neurological symptoms and quality of life.

Conclusion

This case provides preliminary evidence that T-DXd may achieve deep and durable intracranial responses even in heavily pretreated patients with active BMs, including those previously treated with WBRT and T-DM1. The exceptional duration of response observed in this case appears to exceed historical expectations and warrants further investigation in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

Blood-brain barrierBrain metastasesCase reportHuman epidermal growth factor 2-positive breast cancerTrastuzumab deruxtecan

Autor:innen und Institutionen

  • Department of Human Pathology "G. Barresi", School of Specialization in Medical Oncology, University of Messina, Messina, Italy.
  • Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.
  • Casa di Cura Villa Salus, Messina, Italy.
  • Medical Oncology Unit Casa di Cura Villa Salus, Messina, Italy.
  • Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, Ferrara, Italy.

Zitieren

APA

Musarra, M., Danzè, M., Marafioti, M., Di Mauro, G., Incognito, D., Portillo Funes, J. A., Franchina, T., Santarpia, M., Donato, M., Ciappina, G., & Ingemi, M. C. (2026). Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review. Case Reports in Oncology, 19(1), 767-776. https://doi.org/10.1159/000552141

Vancouver

Musarra M, Danzè M, Marafioti M, Di Mauro G, Incognito D, Portillo Funes JA, et al. Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review. Case Reports in Oncology. 2026;19(1):767-776. doi:10.1159/000552141

BibTeX
@article{Musarra2026,
  author = {Musarra, Martina and Danzè, Mariafernanda and Marafioti, Mariapia and Di Mauro, Giordana and Incognito, Dalila and Portillo Funes, Jessica Alejandra and Franchina, Tindara and Santarpia, Mariacarmela and Donato, Marco and Ciappina, Giuliana and Ingemi, Maria Concetta},
  title = {Long-Term Complete Radiological Response in a Patient with Brain Metastases from HER2-Positive Breast Cancer Treated with Trastuzumab Deruxtecan: A Case Report and Literature Review},
  journal = {Case Reports in Oncology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {767--776},
  doi = {10.1159/000552141}
}
Kostenlos starten →